Hemmo Pharmaceuticals Private Limited, a amalgamated private limited company, was established on 07 November 1979 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U17100MH1979PTC021857. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹2.91 M.
Formerly known as Jashan Textile Mills Private Limited. It upholds a compliant status. Employing 325 professional, Its leadership includes Surinder Bhawanidas Gulati (Director), Madhu Vikram Utamsingh (Director), Amit Anant Bapat (Director). Past directors included Rekha Jairam Hemrajani, Surinder Bhawanidas Gulati, Savita Jairam Hemrajani. It holds ₹25.00 Cr open charges and ₹1.06 Cr settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at 114, Turf Estate, 3/65, Off Dr. E. Moses Road, Mahalaxmi,, Mumbai, Maharashtra, 400011.
U17100MH1979PTC021857
021857
07 November 1979
₹5.00 M
₹2.91 M
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Hemmo Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Surinder Bhawanidas Gulati | Director | 22 Jun 2021 | Current |
| Madhu Vikram Utamsingh | Director | 01 Aug 2008 | Current |
| Amit Anant Bapat | Director | 26 Nov 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Jun 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Nov 2021 | Past |
| Pramod Abcsdd | Director | 19 Jun 2019 | Past |
| Pramod Abcsdd | Managing Director | 22 Jun 2021 | Past |
| Pramod Abcsdd | Director | 22 Jun 2021 | Past |
| Pramod Abcsdd | Additional Director | 26 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hemmo Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 44.62% increase. The company also saw a substantial improvement in profitability, with a 68.07% increase in profit. The company's net worth Soared by an impressive increase of 39.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Hemmo Pharmaceuticals had a promoter holding of 100.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹250,000,000.00
₹10,629,962.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Mar 2022 | Axis Bank Limited | ₹25.00 Cr | Open |
| 22 Sep 1998 | Indian Overseas Bank | ₹0.32 M | Satisfied |
| 18 Sep 1995 | Oriental Bank Of Commerce | ₹5.00 M | Satisfied |
| 03 Oct 1992 | Oriental Bank Of Commerce | ₹2.00 M | Satisfied |
| 19 May 1992 | Oriental Bank Of Commerce | ₹1.50 M | Satisfied |
Explore comprehensive loan charge details -
Hemmo Pharmaceuticals has a workforce of 325 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Hemmo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemmo Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Axis Bank Limited amounted to Rs. 250.00 M with Charge ID 100561084 was registered on 23 Mar 2022. was recorded as a recent event.
Hemmo Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
The activity Amit Anant Bapat was appointed as a Director was appointed as a Director on 26 Nov 2021 & has been associated with this company since 4 years 6 days . was completed.
Progress on Surinder Bhawanidas Gulati was appointed as a Director was appointed as a Director on 22 Jun 2021 & has been associated with this company since 4 years 5 months . was documented.
Progress on Hemmo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was documented.
The activity A charge registered on 22 Sep 1998 via Charge ID 90218208 with Indian Overseas Bank was fully satisfied on 11 Feb 2016. was completed.
The CIN of Hemmo Pharmaceuticals Private Limited is U17100MH1979PTC021857.
Hemmo Pharmaceuticals Private Limited is headquartered at 114, Turf Estate, 3/65, Off Dr. E. Moses Road, Mahalaxmi,, Mumbai, Maharashtra, 400011.
Hemmo Pharmaceuticals Private Limited was incorporated on 07 November 1979.
The current directors of Hemmo Pharmaceuticals Private Limited are
The primary industry of Hemmo Pharmaceuticals Private Limited is Manufacturing.
Hemmo Pharmaceuticals Private Limited is unlisted.
The authorized capital of Hemmo Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹2.91 M.
The compliance status of Hemmo Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX